Detalles de la búsqueda
1.
Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.
Bioorg Med Chem
; 23(10): 2387-407, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882525
2.
Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
Bioorg Med Chem
; 22(17): 4998-5012, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25009002
3.
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
J Med Chem
; 59(7): 3392-408, 2016 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27003761
4.
Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
J Med Chem
; 62(17): 8364, 2019 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424209
5.
Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors.
J Med Chem
; 53(5): 2171-87, 2010 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20141146
6.
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor.
J Med Chem
; 52(16): 5152-63, 2009 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19603809
Resultados
1 -
6
de 6
1
Próxima >
>>